Neurobiology of Aging
Volume 28, Issue 8 , Pages 1206-1214 , August 2007

Noradrenaline deficiency in brain increases β-amyloid plaque burden in an animal model of Alzheimer's disease

  • Sergey Kalinin

      Affiliations

    • Department of Anesthesiology, University of Illinois, & Jesse Brown Veteran's Affairs Research Division, Chicago, IL 60612, United States
    • ,
  • Vitaliy Gavrilyuk

      Affiliations

    • Department of Anesthesiology, University of Illinois, & Jesse Brown Veteran's Affairs Research Division, Chicago, IL 60612, United States
    • ,
  • Paul E. Polak

      Affiliations

    • Department of Anesthesiology, University of Illinois, & Jesse Brown Veteran's Affairs Research Division, Chicago, IL 60612, United States
    • ,
  • Robert Vasser

      Affiliations

    • Northwestern University, Chicago, IL 60611, United States
    • ,
  • Jie Zhao

      Affiliations

    • Northwestern University, Chicago, IL 60611, United States
    • ,
  • Michael T. Heneka

      Affiliations

    • Department of Neurology, University of Muenster, Muenster, Germany
    • ,
  • Douglas L. Feinstein

      Affiliations

    • Department of Anesthesiology, University of Illinois, & Jesse Brown Veteran's Affairs Research Division, Chicago, IL 60612, United States
    • Corresponding Author InformationCorrespondence to: 835 South Wolcott Street, MC513, Room E720, Chicago, IL 60612, United States. Tel.: +1 312 355 1665; fax: +1 312 996 9627.

Received 11 October 2005 ,Revised 26 May 2006 ,Accepted 2 June 2006.

References 

  1. Bickford PC, Mosimann WF, Hoffer BJ, Freedman R. Effects of the selective noradrenergic neurotoxin DSP4 on cerebellar Purkinje neuron electrophysiology. Life Sci. 1984;34(8):731–741
  2. Bondareff W, Mountjoy CQ, Roth M, Rossor MN, Iversen LL, Reynolds GP, et al. Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease. Alzheimer Dis Assoc Disord. 1987;1(4):256–262
  3. Caccamo A, Oddo S, Sugarman MC, Akbari Y, LaFerla FM. Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders. Neurobiol Aging. 2005;26(5):645–654
  4. Dello Russo C, Boullerne AI, Gavrilyuk V, Feinstein DL. Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production. J Neuroinflammat. 2004;1(1):9
  5. Dodart JC, Meziane H, Mathis C, Bales KR, Paul SM, Ungerer A. Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Behav Neurosci. 1999;113(5):982–990
  6. Eckman EA, Eckman CB. Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention. Biochem Soc Trans. 2005;33(Pt 5):1101–1105
  7. Fiala M, Lin J, Ringman J, Kermani-Arab V, Tsao G, Patel A, et al. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J Alzheimers Dis. 2005;7(3):221–232
  8. Fukami S, Watanabe K, Iwata N, Haraoka J, Lu B, Gerard NP, et al. Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology. Neurosci Res. 2002;43(1):39–56
  9. Galea E, Heneka MT, Dello Russo C, Feinstein DL. Intrinsic regulation of brain inflammatory responses. Cell Mol Neurobiol. 2003;23(4–5):625–635
  10. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature. 1995;373(6514):523–527
  11. Gotz J, Schild A, Hoerndli F, Pennanen L. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models. Int J Dev Neurosci. 2004;22(7):453–465
  12. Hama E, Saido TC. Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide. Med Hypotheses. 2005;65(3):498–500
  13. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–356
  14. Heneka MT, Galea E, Gavriluyk V, Dumitrescu-Ozimek L, Daeschner J, O’Banion MK, et al. Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease. J Neurosci. 2002;22(7):2434–2442
  15. Heneka MT, Gavrilyuk V, Landreth GE, O’Banion MK, Weinberg G, Feinstein DL. Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression. J Neurochem. 2003;85(2):387–398
  16. Heneka MT, Ramanathan M, Jacobs AH, Dumitrescu-Ozimek L, Bilkei-Gorzo A, Debeir T, et al. Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J Neurosci. 2006;26(5):1343–1354
  17. Heneka MT, Sastre M, Dumitrescu-Ozimek L, Hanke A, Dewachter I, Kuiperi C, et al. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain. 2005;128(Pt 6):1442–1453
  18. Heneka MT, Wiesinger H, Dumitrescu-Ozimek L, Riederer P, Feinstein DL, Klockgether T. Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease. J Neuropathol Exp Neurol. 2001;60(9):906–916
  19. Herrmann N, Lanctot KL, Khan LR. The role of norepinephrine in the behavioral and psychological symptoms of dementia. J Neuropsychiatry Clin Neurosci. 2004;16(3):261–276
  20. Ho GJ, Drego R, Hakimian E, Masliah E. Mechanisms of cell signaling and inflammation in Alzheimer's disease. Curr Drug Targets Inflamm Allergy. 2005;4(2):247–256
  21. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, Hu K, et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci USA. 1999;96(6):3228–3233
  22. Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, et al. Metabolic regulation of brain Abeta by neprilysin. Science. 2001;292(5521):1550–1552
  23. Javierre MQ, Pinto LV, Lima AO, Sassine WA. Immunologic phagocytosis by macrophages: effect by stimulation of alpha adrenergic receptors. Rev Bras Pesqui Med Biol. 1975;8(3–4):271–274
  24. Jonsson G, Hallman H, Ponzio F, Ross S. DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)—a useful denervation tool for central and peripheral noradrenaline neurons. Eur J Pharmacol. 1981;72(2–3):173–188
  25. Kalinin S, Polak PE, Madrigal J, Gavrilyuk V, Sharp V, Chauhan N, et al. Beta-amyloid dependent expression of inducible nitric oxide synthase in neurons: prevention by an a2-adrenergic receptor antagonist. Antioxidant Redox Signal. 2005;8(5–6):873–933
  26. Lee SC, Zhao ML, Hirano A, Dickson DW. Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques. J Neuropathol Exp Neurol. 1999;58(11):1163–1169
  27. Lee VM, Page CD, Wu HL, Schlaepfer WW. Monoclonal antibodies to gel-excised glial filament protein and their reactivities with other intermediate filament proteins. J Neurochem. 1984;42(1):25–32
  28. Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci. 2000;20(15):5709–5714
  29. Makranz C, Cohen G, Reichert F, Kodama T, Rotshenker S. cAMP cascade (PKA, Epac, adenylyl cyclase, Gi, and phosphodiesterases) regulates myelin phagocytosis mediated by complement receptor-3 and scavenger receptor-AI/II in microglia and macrophages. Glia. 2006;53(4):441–448
  30. Mann DM. The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system. Mech Ageing Dev. 1983;23(1):73–94
  31. Mann DM, Yates PO, Hawkes J. The noradrenergic system in Alzheimer and multi-infarct dementias. J Neurol Neurosurg Psychiatry. 1982;45(2):113–119
  32. Mann DM, Yates PO, Hawkes J. The pathology of the human locus ceruleus. Clin Neuropathol. 1983;2(1):1–7
  33. Marien MR, Colpaert FC, Rosenquist AC. Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Brain Res Rev. 2004;45(1):38–78
  34. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, et al. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci. 2000;20(11):4050–4058
  35. Ortega E, Marchena JM, Garcia JJ, Barriga C, Rodriguez AB. Norepinephrine as mediator in the stimulation of phagocytosis induced by moderate exercise. Eur J Appl Physiol. 2005;93(5–6):714–718
  36. Palmer AM, DeKosky ST. Monoamine neurons in aging and Alzheimer's disease. J Neural Transm Gen Sect. 1993;91(2–3):135–159
  37. Pardossi-Piquard R, Petit A, Kawarai T, Sunyach C, Alves dC, Vincent B, et al. Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP. Neuron. 2005;46(4):541–554
  38. Ressler KJ, Nemeroff CB. Role of norepinephrine in the pathophysiology of neuropsychiatric disorders. CNS Spectr. 2001;6(8):663–670
  39. Roe MT, Dawson DV, Hulette CM, Einstein G, Crain BJ. Microglia are not exclusively associated with plaque-rich regions of the dentate gyrus in Alzheimer's disease. J Neuropathol Exp Neurol. 1996;55(3):366–371
  40. Ross SB. Long-term effects of N-2-chlorethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurones in the rat brain and heart. Br J Pharmacol. 1976;58(4):521–527
  41. Russo R, Borghi R, Markesbery W, Tabaton M, Piccini A. Neprylisin decreases uniformly in Alzheimer's disease and in normal aging. FEBS Lett. 2005;579(27):6027–6030
  42. Saito T, Iwata N, Tsubuki S, Takaki Y, Takano J, Huang SM, et al. Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation. Nat Med. 2005;11(4):434–439
  43. Sambamurti K, Kinsey R, Maloney B, Ge YW, Lahiri DK. Gene structure and organization of the human beta-secretase (BACE) promoter. FASEB J. 2004;18(9):1034–1036
  44. Shie FS, Breyer RM, Montine TJ. Microglia lacking E Prostanoid Receptor subtype 2 have enhanced Abeta phagocytosis yet lack Abeta-activated neurotoxicity. Am J Pathol. 2005;166(4):1163–1172
  45. van der Velden V, Naber BA, van der SP, Hoogsteden HC, Versnel MA. Cytokines and glucocorticoids modulate human bronchial epithelial cell peptidases. Cytokine. 1998;10(1):55–65
  46. Vodovotz Y, Lucia MS, Flanders KC, Chesler L, Xie QW, Smith TW, et al. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J Exp Med. 1996;184(4):1425–1433
  47. Yan Q, Zhang J, Liu H, Babu-Khan S, Vassar R, Biere AL, et al. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J Neurosci. 2003;23(20):7504–7509
  48. Zlokovic BV. Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 2005;28(4):202–208
  49. Zou LB, Mouri A, Iwata N, Saido TC, Wang D, Wang MW, et al. Inhibition of neprilysin by infusion of thiorphan into the hippocampus causes an accumulation of amyloid Beta and impairment of learning and memory. J Pharmacol Exp Ther. 2006;317(1):334–340

PII: S0197-4580(06)00197-7

doi: 10.1016/j.neurobiolaging.2006.06.003

Neurobiology of Aging
Volume 28, Issue 8 , Pages 1206-1214 , August 2007

Article Tools

* Image Usage & Resolution